Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples